Terns Pharmaceuticals Stock Forward View - Price Action Indicator
| TERN Stock | USD 34.60 0.40 1.17% |
Terns Stock outlook is based on your current time horizon.
As of today, The value of RSI of Terns Pharmaceuticals' share price is at 52. This usually implies that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Terns Pharmaceuticals, making its price go up or down. Momentum 52
Impartial
Oversold | Overbought |
Using Terns Pharmaceuticals hype-based prediction, you can estimate the value of Terns Pharmaceuticals from the perspective of Terns Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
Terns Pharmaceuticals after-hype prediction price | USD 34.6 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Terns Pharmaceuticals to cross-verify your projections. Terns Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Terns price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Terns using various technical indicators. When you analyze Terns charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Terns Pharmaceuticals Volatility | Backtest Terns Pharmaceuticals | Information Ratio |
Terns Pharmaceuticals Trading Date Momentum
| On February 01 2026 Terns Pharmaceuticals was traded for 34.60 at the closing time. The top price for the day was 35.97 and the lowest listed price was 33.53 . There was no trading activity during the period 0.0. Lack of trading volume on February 1, 2026 did not result in any price rise and fall. The trading price change against the current closing price is 1.21% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Terns Pharmaceuticals to competition |
Other Forecasting Options for Terns Pharmaceuticals
For every potential investor in Terns, whether a beginner or expert, Terns Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Terns Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Terns. Basic forecasting techniques help filter out the noise by identifying Terns Pharmaceuticals' price trends.Terns Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Terns Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Terns Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Terns Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Terns Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Terns Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Terns Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Terns Pharmaceuticals stock market strength indicators, traders can identify Terns Pharmaceuticals entry and exit signals to maximize returns.
Terns Pharmaceuticals Risk Indicators
The analysis of Terns Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Terns Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting terns stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.34 | |||
| Semi Deviation | 2.31 | |||
| Standard Deviation | 6.81 | |||
| Variance | 46.41 | |||
| Downside Variance | 9.28 | |||
| Semi Variance | 5.31 | |||
| Expected Short fall | (5.89) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Terns Pharmaceuticals
The number of cover stories for Terns Pharmaceuticals depends on current market conditions and Terns Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Terns Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Terns Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Terns Pharmaceuticals Short Properties
Terns Pharmaceuticals' future price predictability will typically decrease when Terns Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Terns Pharmaceuticals often depends not only on the future outlook of the potential Terns Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Terns Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 79.5 M | |
| Cash And Short Term Investments | 358.2 M |
Check out Historical Fundamental Analysis of Terns Pharmaceuticals to cross-verify your projections. To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Will Stock sector continue expanding? Could Terns diversify its offerings? Factors like these will boost the valuation of Terns Pharmaceuticals. If investors know Terns will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Terns Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Terns Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects Terns's accounting equity. The concept of intrinsic value—what Terns Pharmaceuticals' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Terns Pharmaceuticals' price substantially above or below its fundamental value.
Please note, there is a significant difference between Terns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Terns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Terns Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.